Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial.
Taku AsanoToru TanigakiMasahiro HoshinoMotoki YasunagaHideaki NonakaHiroki EmoriYuki KatagiriYosuke MiyazakiYohei SotomiNorihiro KogameShoichi KuramitsuAkira SaitoKotaro MiyataYoshimitsu TakaokaTakayoshi KanieManabu YamasakiKunihiko YoshinoNaoki WakabayashiKouki OuchiHiroyuki KodamaYumi ShiinaRihito TamakiYosuke NishihataKeita MasudaTakahiro SuzukiJohan H C ReiberTakayuki OkamuraYoshiharu HiguchiTsunekazu KakutaHiroyasu MisumiKohei AbeNobuyuki KomiyamaKengo TanabeHitoshi MatsuoOn Behalf Of The Decision Qfr InvestigatorsPublished in: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology (2024)
QFR provided feasible physiological data in Heart Team discussions to determine the optimal revascularisation strategy for MVD. The QFR and FFR approaches agreed substantially in terms of treatment recommendations.
Keyphrases
- study protocol
- clinical trial
- palliative care
- heart failure
- double blind
- open label
- phase iii
- quality improvement
- atrial fibrillation
- phase ii
- randomized controlled trial
- percutaneous coronary intervention
- electronic health record
- st elevation myocardial infarction
- high resolution
- st segment elevation myocardial infarction
- clinical practice
- placebo controlled
- mass spectrometry
- machine learning
- data analysis